-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

623.O1.6 623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Response Adapted Therapy and New Combinations in Hodgkin Lymphoma

Lymphoma: Chemotherapy, excluding Pre-Clinical Models Program: Oral and Poster Abstracts
Type: Oral
Monday, December 7, 2015: 10:30 AM-12:00 PM
Tangerine 3 (WF3-4), Level 2 (Orange County Convention Center)
Moderators:
Andrew Evens, DO, MSc, FACP, Tufts Medical Center and Nancy L Bartlett, MD, Washington University School of Medicine, Siteman Cancer Center

Disclosures:
No relevant conflicts of interest to declare.
10:30 AM

Olivier Casasnovas, MD1*, Pauline Brice, MD2, Reda Bouabdallah, MD3, Gilles A. Salles, MD, PhD4, Aspasia Stamatoullas, MD5*, Jehan Dupuis, MD6*, Oumedaly Reman, MD7, Thomas Gastinne, MD8*, Bertrand Joly, MD9*, Krimo Bouabdallah, MD10*, Emmanuelle Nicolas-Virelizier, MD11*, Serge Bologna, MD12*, Franck Morschhauser, MD13*, Richard Delarue, MD14, Hassan Farhat, MD15*, Philippe Quittet, MD16, Alina Berriolo-Riedinger, MD17*, Adrian Tempescul18*, Véronique Edeline, MD19*, Herve Maisonneuve, MD20*, Jean Claude Eisenmann, MD21*, Alexandra Traverse-Glehen22*, Marc Andre, MD23*, Nicolas Mounier, MD, PhD24*, Michel Meignan, MD, PhD25* and Christophe Fermé, MD26*

1Hematology Department, Hopital Le Bocage, CHU Dijon, Dijon, France
2Hematology, Hopital Saint-Louis, APHP, Paris, France
3Hematology Department, Lymphoma Program, Institut Paoli-Calmettes, Marseille, France
4Hospices Civils de Lyon, University Claude Bernard, Pierre-Benite, France
5Clinical Hematology, CENTRE HENRI BECQUEREL, Rouen, France
6Lymphoid Malignancies Unit, APHP, Groupe Hospitalier Mondor, CRETEIL, France
7Hematology, CHU, Caen, France
8Hematology Department, CHU Nantes, Nantes, France
9Hematology Department, Centre hospitalier Sud Francilien, Corbeil, France
10CHU de Bordeaux, Bordeaux, France
11Hematology Department, Centre L. Berard, Lyon, France
12Hematology Department, CHU Nancy, Vandoeuvre Les Nancy, France
13Hematologie, Centre Hospitalier Universitaire, Université de Lille 2, Lille, France
14Hematology Department, AP-HP Hôpital Necker, Paris, France
15Hematology Department, CH Versailles, Versailles, France
16Hematology Department, CHU Saint Eloi Montpellier, Montpellier, France
17Nuclear Medicine Department, Centre G.F. Leclerc, Dijon, France
18Hematology Department, CHU Brest, Brest, France
19Nuclear Medicine Department, Institut Curie, Paris, France
20Oncology and Hematology Department, CH, La Roche-sur-Yon, France
21Hematology Department, CH Mulhouse, Mulhouse, France
22Department of Pathology and Hematology, Hospices Civils de Lyon, University Lyon 1, Lyon, France
23Hematology Department, CHU Dinant Godinne, Yvoir, Belgium
24Hematology Department, CHU De Nice, Hopital De L'Archet, Nice, France
25Nuclear Medicine, AP-HP Groupe Hospitalier Mondor, Créteil, France
26Hematology Department, Institut Gustave Roussy, Villejuif, France

10:45 AM

David J. Straus, MD1, Brandelyn Pitcher, MS2*, Lale Kostakoglu, MD, MPH3*, John C Grecula, MD4*, Eric D. Hsi, MD5, Heiko Schoder, MD6*, Sin-Ho Jung, PhD2*, Leslie L. Popplewell, MD7, Julie E Chang, MD8, Craig H Moskowitz, MD6, Nina Wagner-Johnson, MD9*, John P. Leonard, MD10, Jonathan W. Friedberg, MD, MMSc11, Brad S Kahl, MD12, Bruce D. Cheson, MD13 and Nancy L. Bartlett, MD14

1Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Alliance Statistics and Data Center, Duke University, Durham, NC
3Mount Sinai Medical Center, New York, NY
4Ohio State Univeristy, Columbus, OH
5Cleveland Clinic, Cleveland, OH
6Memorial Sloan Kettering Cancer Center, New York, NY
7City of Hope, Duarte, CA
8University of Wisconsin, Madison, WI
9Washington University, Saint Louis, MO
10Weill Cornell Medical College, New York, NY
11University of Rochester, Rochester, NY
12Washington University, St.Louis, MO
13Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC
14Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO

11:00 AM

Kerry J. Savage, MD MSc1,2, Joseph M. Connors, MD1, Diego R Villa, MD MPH1*, Greg Hapgood, MD1, Alina S Gerrie, MD1, Tamara N Shenkier, MD3*, David W Scott, MBChB, PhD4*, Randy D. Gascoyne5, Francois Benard, MD6*, James Morris, MD7*, Tom Pickles, MD7*, Christina Parsons, MD7*, Don Wilson, MD6* and Laurie H. Sehn1

1British Columbia Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, BC, Canada
2Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
3British Columbia Cancer Agency, Department of Medical Oncology, Vancouver, BC, Canada
4British Columbia Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada
5British Columbia Cancer Agency, Centre for Lymphoid Cancer, Department of Pathology and Laboratory Medicine, Vancouver, BC, Canada
6Department of Functional Imaging, British Columbia Agency, Vancouver, Canada
7Department of Radiation Oncology, British Columbia Cancer Agency, Vancouver, Canada

11:15 AM

Peter Borchmann, MD1, Dennis A. Eichenauer, MD2*, Annette Pluetschow3*, Heinz Haverkamp4*, Stefanie Kreissl, MD1*, Michael Fuchs3*, Martin Soekler5*, Johannes C. Hellmuth, MD6*, Julia Meissner, MD7*, Stephan Mathas8*, Karolin Behringer, MD1*, Markus Dietlein9*, Carsten Kobe9*, Volker Diehl, MD10 and Andreas Engert11

1Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne, Cologne, Germany
2German Hodgkin Study Group (GHSG) and Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany
3German Hodgkin Study Group, University Hospital Cologne, Cologne, Germany
4German Hodgkin Study Group, Cologne, Germany
5Hematology and Oncology, University of Tuebingen, Tuebingen, Germany
6Department of Internal Medicine III, University Hospital, Munich, Germany
7Department of Hematology, University Hospital of Heidelberg, Heidelberg, Germany
8Max Delbrück Center for Molecular Medicine, Berlin, Germany
9Department of Nuclear Medicine; University Hospital of Cologne, Cologne, Germany
10German Hodgkin Study Group (GHSG), University Hospital of Cologne, Cologne, Germany
11First department of Internal Medicine / German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany

11:30 AM

Armando Santoro, MD1*, Rita Mazza, MD1*, Alessandro Pulsoni, MD2*, Alessandro Re3*, Maurizio Bonfichi, MD4*, Vittorio Ruggero Zilioli, MD5*, Flavia Salvi, MD6*, Antonella Anastasia3*, Stefano Luminari, MD7*, Manuel Gotti, MD4*, Annalisa Peli3*, Anna Marina Liberati, MD8*, Nicola Di Renzo9*, Luca Castagna1*, Laura Giordano1* and Carmelo Carlo-Stella, MD1

1Oncology and Hematology, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy
2Universita La Sapienza, Roma, Italy
3Hematology, Spedali Civili, Brescia, Italy
4Hematology, IRCCS Policlinico San Matteo, Pavia, Italy
5Division of Hematology, Niguarda Ca’ Granda Hospital, Milan, Italy
6Hematology, “SS Antonio e Biagio” Hospital, Alessandria, Italy
7Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy
8SC Oncoematologia, Azienda Ospedaliera S. Maria, Terni, Italy
9Hematology, Ospedale Vito Fazzi, Lecce, Italy

11:45 AM

Ramon Garcia-Sanz, MD PhD1,2,3*, Anna Sureda, MD, PhD4*, Sara Alonso-Alvarez, MD5*, Ana Pilar Gonzalez, MD6*, Antonia Rodriguez, MD, PhD7*, Antonio Salar, MD, PhD8*, Fatima de la Cruz, MD9*, Eva Domingo, MD10*, Miriam Moreno, MD11*, Javier Lopez Sr., MD, PhD12*, Jose Luis Piñana, M.D.13*, Gabriela Rodriguez14*, Miguel Canales15, Antonio Manuel Gurierrez, MD16*, Armando López-Guillermo, MD17, María Dolores Caballero, MD, PhD5*, Silvia Jimenez, BsC18* and Carmen Martinez, MD, PhD19*

1Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), Salamanca, Spain
2Department of Hematology, Hospital Universitario de Salamanca, IBSAL; IBMCC (USAL-CSIC),, Salamanca, Spain
3Hematology, Hospital Universitario de Salamanca-IBSAL, Salamanca, Spain
4Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona, Spain
5Hematology Department, University Hospital of Salamanca, Salamanca, Spain
6H.U.C. de Asturias, Oviedo, Spain
7Hematology Department, University Hospital 12 de Octubre, Madrid, Spain
8Hospital del Mar, Barcelona, Spain
9Hematology and Hemotherapy Unit, Hospital Universitario Virgen del Rocio, Seville, Spain
10ICO oncologia, Hospital Duran i Reynals, Barcelona, Spain
11Hematology Department, Hospital Germans Trias i Pujol, Badalona, Spain
12Department of Hematology, Hospital Ramon y Cajal, Madrid, Spain
13Hematology Department, Hospital Clinico de Valenci, Valencia, Spain
14Hospital Gregorio Marañón, Madrid, Spain
15Department of Hematology, Hospital Universitario La Paz, Madrid, Spain
16Hematology Department, Hospital Son Espases, Palma de Mallorca, Spain
17Hematology, Hospital Clínic, Barcelona, Spain
18Department of Pharmacy, University Hospital of Salamanca, Salamanca, Spain
19Hematology Department, Institute of Hematology and Oncology, University of Barcelona, Hospital Clínic, Barcelona, Spain

*signifies non-member of ASH